Medical Affairs Reputations (US) [CLL] - Healthcare Market Research Reports
How well does your CLL medical affairs team performance compare with the rest? Is ‘moderately satisfied’ good enough? According to this latest survey of 100 US medical oncologists and haematologists, the performance of chronic lymphocytic leukaemia medical affairs teams still has a way to go in some key areas before higher satisfaction ratings can be achieved across the board. Find out what physicians think is done well; what they want to see more of; and why some are dissatisfied. Use Medical Affairs Reputations : Chronic Lymphocytic Leukaemia 2017 (US) to discover how your team can better meet the high expectations of physicians at the frontline. This report compares the current activities of medical affairs teams for the six leading CLL treatments from Novartis, Gilead, Roche, Janssen Biotech, AbbVie and Biogen. It shows: How physicians rate each team overall, and for 12 key medical affairs services. What is most important to physicians, plus what can be ...